Notícias Mainz BioMed NV - MYNZ | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Mainz BioMed NV (MYNZ)
Mainz BioMed NV (MYNZ) Notícias

Mainz BioMed NV (MYNZ)

4,77

0,99

(26,19%)

Fechado 19 Dezembro 6:00PM

Atrasado por 15 minutos

5,02

0,25

( 5,24% )

Pré-mercado: 7:24AM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mainz Biomed Announces Stock Split

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Mainz BioMed NV

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições